25.05.2024 12:15:47 - *DJ Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio
(MORE TO FOLLOW) Dow Jones Newswires
May 25, 2024 06:15 ET (10:15 GMT)
|
Name |
WKN |
Börse |
Kurs |
Datum/Zeit |
Diff. |
Diff. % |
Geld |
Brief |
Erster |
Schluss |
|
NOVARTIS NAM. SF 0,49 |
904278 |
Hamburg |
0,000 |
26.09.24 16:23:51 |
±0,000 |
±0,00% |
0,000 |
0,000 |
0,000 |
80,190 |
|
NOVARTIS NAM. ADR 1 |
907122 |
Frankfurt |
103,500 |
26.09.24 13:01:57 |
+2,000 |
+1,97% |
102,500 |
104,500 |
102,500 |
101,500 |